Cao, M. (2025) “The Efficacy and Safety of Empagliflozin in Elderly Patients with Type 2 Diabetes Mellitus Complicating Cardiorenal Syndromes Type II and IV: Evaluation of Empagliflozin in CRS”, Journal of Medical Biochemistry, 44(4), pp. 905–914. doi:10.5937/jomb0-54743.